Newsroom

Sorted by: Latest

-

Mayville Engineering Company Announces Pricing of $86.9 Million Underwritten Public Offering of Common Stock

MILWAUKEE--(BUSINESS WIRE)--Mayville Engineering Company (NYSE: MEC) (the “Company” or “MEC”), a leading value-added provider of design, prototyping and manufacturing solutions serving diverse end markets, today announced the pricing of its underwritten public offering of 4,348,000 shares of its common stock at a public offering price of $20 per share, for total gross proceeds of approximately $86.9 million, before deducting underwriting discounts and commissions and other offering expenses pay...
-

The LYCRA Company to Successfully Complete Comprehensive Financial Restructuring

WILMINGTON, Del.--(BUSINESS WIRE)--The LYCRA Company completes financial restructuring, emerges from Chapter 11 with reduced debt and new capital to drive innovation and global growth....
-

Amkor Technology Expands U.S. Advanced Packaging Footprint with Additional Land in Arizona

TEMPE, Ariz.--(BUSINESS WIRE)--Amkor Technology Expands U.S. Advanced Packaging Footprint with Additional Land in Arizona...
-

Pacific Prime Unveiled the Global Employee Benefits Trends Report 2026

HONG KONG--(BUSINESS WIRE)--Pacific Prime, a leading global health insurance brokerage and employee benefits specialist, unveiled its latest Global Employee Benefits Trends Report (GEBTR) 2026. The report shines lights on the global businesses’ responses to the pressing cost challenges and evolving workplace demographics. Cost dominates benefits strategies for employers worldwide, while evolving workplace demographics also call for benefits that are more responsive to employees at differing lif...
-

UBIQUITI INC. INVESTOR ALERT: Haeggquist & Eck, LLP Investigates Ubiquiti Inc.’s Directors and Officers for Breach of Fiduciary Duties – UI

SAN DIEGO--(BUSINESS WIRE)--Haeggquist & Eck, LLP Investigates Ubiquiti Inc.’s Directors and Officers for Breach of Fiduciary Duties...
-

BLUE OWL CAPITAL INC. INVESTOR ALERT: Haeggquist & Eck, LLP Announces Investigation of Blue Owl Capital Inc.’s Directors and Officers for Breach of Fiduciary Duties – OWL

SAN DIEGO--(BUSINESS WIRE)--Haeggquist & Eck, LLP Announces Investigation of Blue Owl Capital Inc.’s Directors and Officers for Breach of Fiduciary Duties...
-

Hunter Point Capital Expands Global Presence with New Hong Kong Office

HONG KONG--(BUSINESS WIRE)--Hunter Point Capital (“HPC”), an independent investment firm providing strategic capital and partnership solutions to alternative asset managers, today announced the opening of its Hong Kong office, establishing a permanent presence in Asia Pacific as part of the firm’s continued global expansion. Led by Managing Director and Head of Asia Pacific Peter Rosenbloom, the new office reinforces HPC’s commitment to delivering its platform of differentiated private markets...
-

Redwood Trust Prices $125.0 Million Senior Notes Offering

MILL VALLEY, Calif.--(BUSINESS WIRE)--Redwood Trust, Inc. (NYSE: RWT; “Redwood” or the “Company”) today announced the pricing of an underwritten public offering of $125,000,000 aggregate principal amount of its 9.75% senior notes due 2031 (the “Notes”). In connection with the offering, Redwood granted the underwriters a 30-day option to purchase up to an additional $18,750,000 aggregate principal amount of Notes, to cover over-allotments. The offering is expected to close on May 27, 2026, subje...
-

ImmunityBio Announces FDA Acceptance of Supplemental BLA for ANKTIVA® Plus BCG in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Papillary Disease; PDUFA Date Set for January 6, 2027

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the U.S. Food and Drug Administration has accepted for review the supplemental Biologics License Application (sBLA) for ANKTIVA® (nogapendekin alfa inbakicept-pmln) in combination with Bacillus Calmette-Guerin (BCG) for the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with papillary disease without carcinoma in situ (CIS...
-

Rosen Law Firm Urges Commvault Systems, Inc. (NASDAQ: CVLT) Stockholders to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Commvault Systems, Inc. (NASDAQ: CVLT) between April 29, 2025 and January 26, 2026, inclusive (the “Class Period”). Commvault is a data protection company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Commvault Systems, In...